News | Sutro Biopharma, Inc.

Sutro Biopharma to Host a Virtual KOL Event to Provide Clinical Update on Antibody-Drug Conjugate STRO-002 in Ovarian Cancer

Events, News, Presentations, Press Releases

Sutro Biopharma to Host a Virtual KOL Event to Provide Clinical Update on Antibody-Drug Conjugate STRO-002 in Ovarian Cancer – Discussion of STRO-002 Data and Program Expansion at 5pm ET / 2pm PTon Dec. 3rd – SOUTH SAN FRANCISCO, Calif., Nov. 24, 2020 – Sutro...

Sutro Biopharma Announces the Appointment of Diana Landa as Vice President of Regulatory Affairs and Annie Chang as Head of Investor Relations

News, Press Releases

Sutro Biopharma Announces the Appointment of Diana Landa as Vice President of Regulatory Affairs and Annie Chang as Head of Investor Relations SOUTH SAN FRANCISCO, Calif., Nov. 18, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery,...

Sutro Biopharma to Participate in Four Upcoming Investor Conferences

Events, News, Presentations, Press Releases

Sutro Biopharma to Participate in Four Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., Nov. 11, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development, and manufacturing company, today announced that Chief Executive...

ADC Review – Onco’Zine

News

ADC Review – Onco’Zine Annual World ADC – Best New Drug Developer 2020: Sutro Biopharma’s Journey to Success https://www.adcreview.com/opinion/annual-world-adc-best-new-drug-developer-2020-sutro-biopharmas-journey-to-success/ William J. Newell Published...

Sutro Biopharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights and Developments

News, Press Releases

Sutro Biopharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights and Developments – KOL Discussion of STRO-002 Data Event scheduled for December 3rd – Interim Phase 1 data from STRO-001 for patients with NHL will be presented...

American Society of Hematology Conference 2020 – STRO-001 – Abstract

News, Presentations

American Society of Hematology Conference 2020 – STRO-001 – Abstract To view the abstract on ASH click here, ASH Website Preliminary Results of an Ongoing Phase 1 Dose Escalation Study of the Novel Anti-CD74 Antibody Drug Conjugate (ADC), STRO-001, in Patients with...

« Older Entries

Next Entries »